pirenzepine has been researched along with Trichotillomania in 4 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
Trichotillomania: Compulsion to pull out one's hair.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Twenty-one patients were screened and 18 patients were enrolled in a 3-month open-label study of olanzapine for trichotillomania (diagnosis based on modified DSM-IV criteria)." | 9.10 | An open-label, flexible-dose study of olanzapine in the treatment of trichotillomania. ( Nejtek, VA; Stewart, RS, 2003) |
| " We present three patients with excoriated acne, self-induced skin ulcers, and trichotillomania, respectively, whose symptoms responded favorably to a 2- to 4-week course of the atypical antipsychotic olanazpine at a dosage of 2." | 5.31 | Olanzapine is effective in the management of some self-induced dermatoses: three case reports. ( Gupta, AK; Gupta, MA, 2000) |
| "Twenty-one patients were screened and 18 patients were enrolled in a 3-month open-label study of olanzapine for trichotillomania (diagnosis based on modified DSM-IV criteria)." | 5.10 | An open-label, flexible-dose study of olanzapine in the treatment of trichotillomania. ( Nejtek, VA; Stewart, RS, 2003) |
| " We present three patients with excoriated acne, self-induced skin ulcers, and trichotillomania, respectively, whose symptoms responded favorably to a 2- to 4-week course of the atypical antipsychotic olanazpine at a dosage of 2." | 1.31 | Olanzapine is effective in the management of some self-induced dermatoses: three case reports. ( Gupta, AK; Gupta, MA, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stewart, RS | 1 |
| Nejtek, VA | 1 |
| Potenza, MN | 1 |
| Wasylink, S | 1 |
| Epperson, CN | 1 |
| McDougle, CJ | 1 |
| Gupta, MA | 1 |
| Gupta, AK | 1 |
| Ashton, AK | 1 |
1 trial available for pirenzepine and Trichotillomania
| Article | Year |
|---|---|
An open-label, flexible-dose study of olanzapine in the treatment of trichotillomania.
Topics: Adolescent; Adult; Age of Onset; Antipsychotic Agents; Anxiety Disorders; Benzodiazepines; Depressiv | 2003 |
3 other studies available for pirenzepine and Trichotillomania
| Article | Year |
|---|---|
Olanzapine augmentation of fluoxetine in the treatment of trichotillomania.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Female; Fluoxetine; Humans; | 1998 |
Olanzapine is effective in the management of some self-induced dermatoses: three case reports.
Topics: Acne Vulgaris; Adult; Antipsychotic Agents; Benzodiazepines; Female; Humans; Olanzapine; Pirenzepine | 2000 |
Olanzapine augmentation for trichotillomania.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Female; Fluoxetine; Humans; | 2001 |